Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


27.08.2018

1 Am J Cardiol
1 Am J Ophthalmol
1 Ann Intern Med
1 Diabet Med
6 Diabetes
8 Diabetes Care
1 Diabetes Educ
8 Diabetes Obes Metab
5 Diabetologia
1 Invest Ophthalmol Vis Sci
3 J Clin Endocrinol Metab
2 J Diabetes Complications
1 J Immunol
2 Lancet
3 Lancet Diabetes Endocrinol
2 Obstet Gynecol
2 Ophthalmology
5 Pediatr Diabetes
5 PLoS One
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Cardiol

  1. ISSA M, Alqahtani F, Ziada KM, Stanazai Q, et al
    Incidence and Outcomes of Non-ST Elevation Myocardial Infarction in Patients Hospitalized with Decompensated Diabetes.
    Am J Cardiol. 2018 Jul 17. pii: S0002-9149(18)31412.
    PubMed     Text format     Abstract available


    Am J Ophthalmol

  2. MORA N, Kempen JH, Sobrin L
    Diabetic Retinopathy in Hispanics: A Perspective on Disease Burden.
    Am J Ophthalmol. 2018 Aug 20. pii: S0002-9394(18)30473.
    PubMed     Text format     Abstract available


    Ann Intern Med


  3. Prevention of Diabetes With Mediterranean Diets.
    Ann Intern Med. 2018;169:271-272.
    PubMed     Text format    


    Diabet Med

  4. SINGH K, Johnson L, Devarajan R, Shivashankar R, et al
    Acceptability of a decision-support electronic health record system and its impact on diabetes care goals in South Asia: a mixed-methods evaluation of the CARRS trial.
    Diabet Med. 2018 Aug 24. doi: 10.1111/dme.13804.
    PubMed     Text format     Abstract available


    Diabetes

  5. FANG H, Hu N, Zhao Q, Wang B, et al
    mtDNA Haplogroup N9a Increases the Risk of Type 2 Diabetes by Altering Mitochondrial Function and Intracellular Mitochondrial Signals.
    Diabetes. 2018;67:1441-1453.
    PubMed     Text format     Abstract available

  6. KONO T, Tong X, Taleb S, Bone RN, et al
    Impaired Store-Operated Calcium Entry and STIM1 Loss Lead to Reduced Insulin Secretion and Increased Endoplasmic Reticulum Stress in the Diabetic beta cell.
    Diabetes. 2018 Aug 21. pii: db17-1351. doi: 10.2337/db17-1351.
    PubMed     Text format     Abstract available

  7. MILLER BS, Blumenthal SR, Shalygin A, Wright KD, et al
    Inactivation of p66Shc Decreases Afferent Arteriolar KATP Channel Activity and Decreases Renal Damage in Diabetic Dahl SS Rats.
    Diabetes. 2018 Aug 21. pii: db18-0308. doi: 10.2337/db18-0308.
    PubMed     Text format     Abstract available

  8. ACCILI D
    Insulin Action Research and the Future of Diabetes Treatment: The 2017 Banting Medal for Scientific Achievement Lecture.
    Diabetes. 2018;67:1701-1709.
    PubMed     Text format     Abstract available

  9. OZCAN L, Tabas I
    A New Activator of Hepatocyte CaMKII in Fasting and Type 2 Diabetes.
    Diabetes. 2018;67:1742-1744.
    PubMed     Text format    

  10. HALUZIK M, Mraz M
    Intermittent Fasting and Prevention of Diabetic Retinopathy: Where Do We Go From Here?
    Diabetes. 2018;67:1745-1747.
    PubMed     Text format    


    Diabetes Care

  11. DESAI U, Kirson NY, Kim J, Khunti K, et al
    Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes.
    Diabetes Care. 2018 Aug 21. pii: dc17-0662. doi: 10.2337/dc17-0662.
    PubMed     Text format     Abstract available

  12. CHENG YJ, Imperatore G, Geiss LS, Saydah SH, et al
    Trends and Disparities in Cardiovascular Mortality Among U.S. Adults With and Without Self-Reported Diabetes Mellitus, 1988-2015.
    Diabetes Care. 2018 Aug 21. pii: dc18-0831. doi: 10.2337/dc18-0831.
    PubMed     Text format     Abstract available

  13. BERG CA, Wiebe DJ, Suchy Y, Turner SL, et al
    Executive Function Predicting Longitudinal Change in Type 1 Diabetes Management During the Transition to Emerging Adulthood.
    Diabetes Care. 2018 Aug 21. pii: dc18-0351. doi: 10.2337/dc18-0351.
    PubMed     Text format     Abstract available

  14. BJERG L, Hulman A, Carstensen B, Charles M, et al
    Development of Microvascular Complications and Effect of Concurrent Risk Factors in Type 1 Diabetes: A Multistate Model From an Observational Clinical Cohort Study.
    Diabetes Care. 2018 Aug 21. pii: dc18-0679. doi: 10.2337/dc18-0679.
    PubMed     Text format     Abstract available

  15. GEISS LS, Bullard KM, Brinks R, Gregg EW, et al
    Considerations in Epidemiologic Definitions of Undiagnosed Diabetes.
    Diabetes Care. 2018;41:1835-1838.
    PubMed     Text format     Abstract available

  16. PEARLMAN BL, Hinds A, Dakaud AZ
    Comment on Bril et al. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients. Diabetes Care 2018;41:187-192.
    Diabetes Care. 2018;41:e136.
    PubMed     Text format    

  17. BRIL F, Cusi K
    Response to Comment on Bril et al. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients. Diabetes Care 2018;41:187-192.
    Diabetes Care. 2018;41:e137-e138.
    PubMed     Text format    


  18. Updates to the Standards of Medical Care in Diabetes-2018.
    Diabetes Care. 2018;41:2045-2047.
    PubMed     Text format    


    Diabetes Educ

  19. POUDEL P, Griffiths R, Wong VW, Arora A, et al
    Perceptions and Practices of Diabetes Educators in Providing Oral Health Care: A Qualitative Study.
    Diabetes Educ. 2018 Aug 24:145721718796055. doi: 10.1177/0145721718796055.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  20. ARNOLD SV, Seman L, Tang F, Peri-Okonny PA, et al
    Real-World Opportunity of Empagliflozin to Improve Blood Pressure Control in African Americans with Type 2 Diabetes: An NCDR(R) "Research-to-Practice" Project From the Diabetes Collaborative Registry (DCR).
    Diabetes Obes Metab. 2018 Aug 23. doi: 10.1111/dom.13510.
    PubMed     Text format     Abstract available

  21. BELL DSH, Goncalves E
    Atrial fibrillation and type 2 diabetes: prevalence, etiology, pathophysiology and effect of anti-diabetic therapies.
    Diabetes Obes Metab. 2018 Aug 24. doi: 10.1111/dom.13512.
    PubMed     Text format     Abstract available

  22. RYAN PB, Rosenthal N
    Comment on Ryan, et al. Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non-SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real-world meta-analysis of 4 ob
    Diabetes Obes Metab. 2018 Aug 23. doi: 10.1111/dom.13509.
    PubMed     Text format     Abstract available

  23. ARNOLD SV, Yap J, Lam CSP, Tang F, et al
    Management of patients with diabetes and heart failure with reduced ejection fraction: an international comparison.
    Diabetes Obes Metab. 2018 Aug 23. doi: 10.1111/dom.13511.
    PubMed     Text format     Abstract available

  24. IDRIS I
    News and Views for September 2018: Highlights from the American Diabetes Association Scientific meeting, June 2018.
    Diabetes Obes Metab. 2018;20:2321-2324.
    PubMed     Text format    

  25. DORIS J, Millar SA, Idris I, O'Sullivan SE, et al
    Genetic Polymorphisms of the Endocannabinoid System in Obesity and Diabetes.
    Diabetes Obes Metab. 2018 Aug 21. doi: 10.1111/dom.13504.
    PubMed     Text format     Abstract available

  26. GARIANI K, Lebowitz D, von Dach E, Kressmann B, et al
    Remission in Diabetic Foot Infections: Duration of Antibiotic Therapy and Other Possible Associated Factors.
    Diabetes Obes Metab. 2018 Aug 21. doi: 10.1111/dom.13507.
    PubMed     Text format     Abstract available

  27. WANG W, Ruiz LN, Filippova E, Song KH, et al
    Efficacy and Safety of Once-weekly Dulaglutide Versus Insulin Glargine in Mainly Asian Patients with Type 2 Diabetes Mellitus on Metformin and/or a Sulfonylurea: a 52-week Open-label, Randomized Phase 3 Trial.
    Diabetes Obes Metab. 2018 Aug 21. doi: 10.1111/dom.13506.
    PubMed     Text format     Abstract available


    Diabetologia

  28. WANNER C, Marx N
    SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseases.
    Diabetologia. 2018 Aug 22. pii: 10.1007/s00125-018-4678.
    PubMed     Text format     Abstract available

  29. LUPSA BC, Inzucchi SE
    Use of SGLT2 inhibitors in type 2 diabetes: weighing the risks and benefits.
    Diabetologia. 2018 Aug 22. pii: 10.1007/s00125-018-4663.
    PubMed     Text format     Abstract available

  30. MCCRIMMON RJ, Henry RR
    SGLT inhibitor adjunct therapy in type 1 diabetes.
    Diabetologia. 2018 Aug 22. pii: 10.1007/s00125-018-4671.
    PubMed     Text format     Abstract available

  31. MARSHALL SM
    The bark giving diabetes therapy some bite: the SGLT inhibitors.
    Diabetologia. 2018 Aug 22. pii: 10.1007/s00125-018-4673.
    PubMed     Text format    


  32. 54(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Berlin, Germany, 1 - 5 October 2018.
    Diabetologia. 2018 Aug 21. pii: 10.1007/s00125-018-4693.
    PubMed     Text format    


    Invest Ophthalmol Vis Sci

  33. WANG N, Zou C, Zhao S, Wang Y, et al
    Fenofibrate Exerts Protective Effects in Diabetic Retinopathy via Inhibition of the ANGPTL3 Pathway.
    Invest Ophthalmol Vis Sci. 2018;59:4210-4217.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  34. ISHII T, Furuya F, Takahashi K, Shikata M, et al
    Angiopoietin-like protein 2 promotes the progression of diabetic kidney disease.
    J Clin Endocrinol Metab. 2018 Aug 17. pii: 5075163. doi: 10.1210/jc.2017-02705.
    PubMed     Text format     Abstract available

  35. LUNDKVIST P, Pereira MJ, Kamble PG, Katsogiannos P, et al
    Glucagon Levels during Short-term SGLT2 Inhibition are Largely Regulated by Glucose Changes in Type 2 Diabetes Patients.
    J Clin Endocrinol Metab. 2018 Aug 17. pii: 5075166. doi: 10.1210/jc.2018-00969.
    PubMed     Text format     Abstract available

  36. YANG Y, Shen F, Huang W, Qin S, et al
    Glucose is involved in the dynamic regulation of m6A in patients with type 2 diabetes.
    J Clin Endocrinol Metab. 2018 Aug 20. pii: 5076003. doi: 10.1210/jc.2018-00619.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  37. LIU M, Li J, Lv X, He Y, et al
    Bilirubin and its changes were negatively associated with diabetic kidney disease incidence and progression: A five-year's cohort study based on 5323 Chinese male diabetic patients.
    J Diabetes Complications. 2018 Aug 11. pii: S1056-8727(18)30513.
    PubMed     Text format     Abstract available

  38. KATSIKI N, Fonseca V, Mikhailidis DP
    Contrast-induced acute kidney injury in diabetes mellitus: Clinical relevance and predisposing factors. Could statins be of benefit?
    J Diabetes Complications. 2018 Aug 10. pii: S1056-8727(18)30621.
    PubMed     Text format    


    J Immunol

  39. PRESA M, Racine JJ, Dwyer JR, Lamont DJ, et al
    A Hypermorphic Nfkbid Allele Contributes to Impaired Thymic Deletion of Autoreactive Diabetogenic CD8(+) T Cells in NOD Mice.
    J Immunol. 2018 Aug 20. pii: jimmunol.1800465. doi: 10.4049/jimmunol.1800465.
    PubMed     Text format     Abstract available


    Lancet

  40. BASINA M, Maahs DM
    Age at type 1 diabetes onset: a new risk factor and call for focused treatment.
    Lancet. 2018;392:453-454.
    PubMed     Text format    

  41. RAWSHANI A, Sattar N, Franzen S, Rawshani A, et al
    Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study.
    Lancet. 2018;392:477-486.
    PubMed     Text format     Abstract available


    Lancet Diabetes Endocrinol


  42. Correction to Lancet Diabetes Endocrinol 2018; 6: 637-46.
    Lancet Diabetes Endocrinol. 2018;6:e17.
    PubMed     Text format    

  43. THE LANCET DIABETES ENDOCRINOL
    Diabetes stigma and discrimination: finding the right words.
    Lancet Diabetes Endocrinol. 2018;6:673.
    PubMed     Text format    

  44. MORGAN J
    Craig Stubing: the art of managing type 1 diabetes.
    Lancet Diabetes Endocrinol. 2018 Aug 21. pii: S2213-8587(18)30261.
    PubMed     Text format    


    Obstet Gynecol

  45. POCOBELLI G, Yu O, Fuller S, Fraser JR, et al
    One-Step Approach to Identifying Gestational Diabetes Mellitus: Association With Perinatal Outcomes.
    Obstet Gynecol. 2018 Aug 17. doi: 10.1097/AOG.0000000000002780.
    PubMed     Text format     Abstract available

  46. POLNASZEK BE, Raghuraman N, Lopez JD, Frolova AL, et al
    Neonatal Morbidity in the Offspring of Obese Women Without Hypertension or Diabetes.
    Obstet Gynecol. 2018 Aug 17. doi: 10.1097/AOG.0000000000002775.
    PubMed     Text format     Abstract available


    Ophthalmology

  47. SRIVASTAV K, Baskaran P
    Re: Zur et al.: OCT biomarkers as functional outcome predictors in diabetic macular edema treated with dexamethasone implant (Ophthalmology. 2018;125:267-275).
    Ophthalmology. 2018;125:e61.
    PubMed     Text format    

  48. NAKASHIMA H, Iwama Y, Tanioka K, Emi K, et al
    Paracentral Acute Middle Maculopathy following Vitrectomy for Proliferative Diabetic Retinopathy: Incidence, Risk Factors, and Clinical Characteristics.
    Ophthalmology. 2018 Aug 17. pii: S0161-6420(18)30905.
    PubMed     Text format     Abstract available


    Pediatr Diabetes

  49. BURCKHARDT MA, Smith G, Cooper MN, Jones TW, et al
    Real-World outcomes of insulin pump compared to injection therapy in a population based sample of children with type 1 diabetes.
    Pediatr Diabetes. 2018 Aug 20. doi: 10.1111/pedi.12754.
    PubMed     Text format     Abstract available

  50. ADOLFSSON P, Riddell MC, Taplin CE, Davis EA, et al
    ISPAD Clinical Practice Consensus Guidelines 2018 Compendium Exercise in children and adolescents with diabetes.
    Pediatr Diabetes. 2018 Aug 22. doi: 10.1111/pedi.12755.
    PubMed     Text format     Abstract available

  51. INSEL R, Knip M
    Prospects for Primary Prevention of Type 1 Diabetes by Restoring a Disappearing Microbe.
    Pediatr Diabetes. 2018 Aug 22. doi: 10.1111/pedi.12756.
    PubMed     Text format     Abstract available

  52. PIHOKER C, Forsander G, Fantahun B, Virmani A, et al
    The delivery of ambulatory diabetes care to children and adolescents with diabetes.
    Pediatr Diabetes. 2018 Aug 24. doi: 10.1111/pedi.12757.
    PubMed     Text format     Abstract available

  53. KAHKOSKA AR, Shay CM, Couch SC, Crandell J, et al
    Sociodemographic Associations of Longitudinal Adiposity in Youth with Type 1 Diabetes.
    Pediatr Diabetes. 2018 Aug 20. doi: 10.1111/pedi.12753.
    PubMed     Text format     Abstract available


    PLoS One

  54. MUGISHO OO, Rupenthal ID, Squirrell DM, Bould SJ, et al
    Intravitreal pro-inflammatory cytokines in non-obese diabetic mice: Modelling signs of diabetic retinopathy.
    PLoS One. 2018;13:e0202156.
    PubMed     Text format     Abstract available


  55. Retraction: Impaired Insulin Signaling Affects Renal Organic Anion Transporter 3 (Oat3) Function in Streptozotocin-Induced Diabetic Rats.
    PLoS One. 2018;13:e0202898.
    PubMed     Text format    

  56. KHAMBATY T, Callahan CM, Stewart JC
    Effect of collaborative depression treatment on risk for diabetes: A 9-year follow-up of the IMPACT randomized controlled trial.
    PLoS One. 2018;13:e0200248.
    PubMed     Text format     Abstract available

  57. SHIN E, Kim JJ, Lee S, Ko KS, et al
    Hemodynamics in diabetic human aorta using computational fluid dynamics.
    PLoS One. 2018;13:e0202671.
    PubMed     Text format     Abstract available

  58. JENG CJ, Hsieh YT, Yang CM, Yang CH, et al
    Development of diabetic retinopathy after cataract surgery.
    PLoS One. 2018;13:e0202347.
    PubMed     Text format     Abstract available


    Transplantation

  59. MAFFI P, Nano R, Monti P, Melzi R, et al
    Islet Allotransplantation in the Bone Marrow of Patients With Type 1 Diabetes: A Pilot Randomized Trial.
    Transplantation. 2018 Aug 20. doi: 10.1097/TP.0000000000002416.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: